Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Anacor Pharmaceuticals Company Profile (NASDAQ:ANAC)

Consensus Ratings for Anacor Pharmaceuticals (NASDAQ:ANAC) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $24.50 (13.61% downside)

Analysts' Ratings History for Anacor Pharmaceuticals (NASDAQ:ANAC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/9/2014Avondale PartnersInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Jefferies GroupBoost Price TargetBuy$24.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Jefferies GroupReiterated RatingBuy$24.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupReiterated RatingBuy$24.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014Jefferies GroupReiterated RatingBuy$24.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Jefferies GroupInitiated CoverageBuy$24.00ViewTweet This Rating  Share This Rating on StockTwits
3/17/2014TheStreetUpgradeSell -> BuyViewTweet This Rating  Share This Rating on StockTwits
10/29/2013Canaccord GenuityBoost Price TargetBuy$17.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
10/21/2013Canaccord GenuityBoost Price TargetBuy$13.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
10/18/2013WedbushBoost Price Target$20.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
10/18/2013Deutsche BankBoost Price TargetBuy$11.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
3/22/2013Canaccord GenuityBoost Price TargetBuy$5.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
3/22/2013WedbushBoost Price TargetOutperform$10.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2013Canaccord GenuityLower Price TargetBuy$9.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2012CapstoneInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss Anacor Pharmaceuticals